Novo Nordisk falls as much as 7% as its obesity growth plan lands short of a catalyst

SentiSense · Published · Updated

Novo Nordisk shares fell as much as 7% intraday on Monday, September 21, 2026, closing down around 6%, after the company used its Capital Markets Day ...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis